YJK-10230-24670
1 vaccination
2 coded responses
4 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 766 / TX
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-10
Survey response — day 0, dose 1MedDRA: Dizziness, Syncope — Feeling: Poor · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Dizziness, feeling faintMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Report sent to call center — day 0, dose 1Be unable to do your normal daily activitiesno matching call case
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Poor · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Dizziness and lightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activitiesno matching call case
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|
2 report(s) with no call case — see the timeline.
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Dizziness, feeling faint
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Dizziness and lightheaded
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Syncope | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release